On 9/11/25, Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 11.5%, closing at $8.34. This advance was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months but has risen 1.8% during the last week.
Current PriceTarget Research Rating
Neogenomics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Neogenomics has a neutral Appreciation Score of 52 but a very low Power Rating of 9, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment